DaVita Inc.

NYSE:DVA Stock Report

Market Cap: US$12.1b

DaVita Future Growth

Future criteria checks 0/6

DaVita's earnings are forecast to decline at 0.7% per annum while its annual revenue is expected to grow at 4.5% per year. EPS is expected to grow by 5% per annum.

Key information

-0.7%

Earnings growth rate

5.0%

EPS growth rate

Healthcare earnings growth17.4%
Revenue growth rate4.5%
Future return on equityn/a
Analyst coverage

Good

Last updated15 Apr 2025

Recent future growth updates

Recent updates

DaVita Inc.'s (NYSE:DVA) Prospects Need A Boost To Lift Shares

Apr 14
DaVita Inc.'s (NYSE:DVA) Prospects Need A Boost To Lift Shares

Returns On Capital At DaVita (NYSE:DVA) Have Stalled

Apr 02
Returns On Capital At DaVita (NYSE:DVA) Have Stalled

We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease

Mar 20
We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease

The DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income Margin

Mar 17

Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)?

Mar 07
Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)?

DaVita: Momentum Could Fade Given High Valuation

Feb 05

Does DaVita (NYSE:DVA) Have A Healthy Balance Sheet?

Jan 30
Does DaVita (NYSE:DVA) Have A Healthy Balance Sheet?

Market Still Lacking Some Conviction On DaVita Inc. (NYSE:DVA)

Dec 15
Market Still Lacking Some Conviction On DaVita Inc. (NYSE:DVA)

DaVita's (NYSE:DVA) Returns On Capital Are Heading Higher

Nov 30
DaVita's (NYSE:DVA) Returns On Capital Are Heading Higher

DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation

Nov 14

Is DaVita Inc. (NYSE:DVA) Potentially Undervalued?

Nov 13
Is DaVita Inc. (NYSE:DVA) Potentially Undervalued?

Is DaVita (NYSE:DVA) A Risky Investment?

Oct 29
Is DaVita (NYSE:DVA) A Risky Investment?

An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

Sep 16
An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued

DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business

Sep 01
DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business
author-image

Critical Investments And Policy Changes Propel Healthcare Innovator Towards Brighter Financial Horizons

Aug 22 DaVita's investments in technology and workforce initiatives aim to enhance revenue operations and patient care, contributing to future growth and profitability.

DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Jul 02
DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet

Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Jun 19
Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?

Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Jun 04
Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?

Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

May 22
Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes

DaVita Stock Is A Hold As It Expands In Latin America

Mar 18

DaVita: Assessing After The Rally

Dec 29

DaVita: Simple And Compelling After Sell-Off

Oct 26

DaVita: Continued Economic Hurdles, Market Expectations May Be Correct

Oct 05

DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold

Jul 21

Earnings and Revenue Growth Forecasts

NYSE:DVA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202714,5158441,1782,1283
12/31/202613,8958631,3932,1857
12/31/202513,4438611,1471,7569
12/31/202412,8169361,4672,022N/A
9/30/202412,6678281,4161,960N/A
6/30/202412,5248601,2691,810N/A
3/31/202412,3388169201,462N/A
12/31/202312,1406921,4912,059N/A
9/30/202311,9115961,3141,918N/A
6/30/202311,7394541,3571,967N/A
3/31/202311,6655001,0771,705N/A
12/31/202211,6105479611,565N/A
9/30/202211,6376801,1521,751N/A
6/30/202211,6278349951,607N/A
3/31/202211,6169031,4792,099N/A
12/31/202111,6199781,2891,931N/A
9/30/202111,5809841,2091,886N/A
6/30/202111,5668831,1241,802N/A
3/31/202111,5297911,1081,773N/A
12/31/202011,5517831,3041,979N/A
9/30/202011,5448321,5062,175N/A
6/30/202011,5248241,6482,333N/A
3/31/202011,4878162,1122,834N/A
12/31/201911,3887051,7302,496N/A
9/30/201911,3116231,4062,235N/A
6/30/201911,2535481,1242,011N/A
3/31/201911,3005512551,208N/A
12/31/201811,4126165441,531N/A
9/30/201811,378617N/A1,592N/A
6/30/201811,299698N/A1,679N/A
3/31/201811,110652N/A1,470N/A
12/31/201710,884909N/A1,966N/A
9/30/20177,7731,065N/A1,983N/A
6/30/20178,7321,480N/A2,016N/A
3/31/20179,7471,382N/A2,391N/A
12/31/201610,6961,038N/A1,988N/A
9/30/201614,550716N/A1,918N/A
6/30/201614,347361N/A2,061N/A
3/31/201614,065478N/A1,576N/A
12/31/20159,973323N/A1,531N/A
9/30/201513,565484N/A1,051N/A
6/30/201513,290452N/A1,219N/A
3/31/201513,027429N/A1,450N/A
12/31/201412,781723N/A1,459N/A
9/30/201412,519727N/A1,884N/A
6/30/201412,270680N/A1,769N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DVA's earnings are forecast to decline over the next 3 years (-0.7% per year).

Earnings vs Market: DVA's earnings are forecast to decline over the next 3 years (-0.7% per year).

High Growth Earnings: DVA's earnings are forecast to decline over the next 3 years.

Revenue vs Market: DVA's revenue (4.5% per year) is forecast to grow slower than the US market (8.3% per year).

High Growth Revenue: DVA's revenue (4.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if DVA's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/15 03:41
End of Day Share Price 2025/04/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

DaVita Inc. is covered by 35 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stephan GasteygerAtlantic Equities LLP
Brian WilliamsAvondale Partners
Matthew GillmorBaird